OpenAlex
PricingAboutJobs
Log inGet started
Work

Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha‐inhibitory dithiolethione in patients with non‐alcoholic fatty liver disease

HTML

Year: 2017
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Alimentary Pharmacology & Therapeutics
DOI: 10.1111/apt.13981
Authors: W. Kim, B. G. Kim, J. S. Lee, C. K. Lee, J. E. Yeon, M. S. Chang, J. H. Kim, H. Kim, S. Yi, J. Lee, J.‐Y. Cho, S. G. Kim, J.‐H. Lee, Y. J. Kim
Language: English

Topic: Liver Disease Diagnosis and Treatment
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: oltipraz, liver X receptor alpha, dithiolethiones, non-alcoholic fatty liver disease, liver fat reduction, dose-dependent efficacy, body mass index, elevated liver enzymes, insulin resistance, liver enzymes, lipid profile, cytokines, adverse events
SDG: Good health and well-being

Open Access status: closed

Funder: Ministry of Knowledge Economy
OpenAlex ID: W2589743422
FWCI: 4.257
Cites: 36
Cited by: 77
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security